$8.25
0.232.87%
At close: Nov 20, 4:00 PM EST
$7.92
-0.33-4%
After Hours: Nov 20, 9:30 AM EST

The average analyst price target for DiaMedica Therapeutics is $12.67, 60.0% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $6 to $25. The latest change came on Nov 14, 2025, when Cantor Fitzgerald initiated coverage of DiaMedica Therapeutics with an Overweight rating and a $25 price target.
Price Target Range — 9 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months